Comparison |
Alternate Manufacturer Number |
3903770 | 3923125 | 1787316 | 2345882 | 2345874 |
Dosage Form |
Capsule | Capsule | Capsule | Tablet | Tablet |
Generic Drug Code |
73441 | 98980 | 73441 | 49459 | 45639 |
Generic Drug Name |
Oseltamivir Phosphate | Oseltamivir Phosphate | Oseltamivir Phosphate | Baloxavir Marboxil | Baloxavir Marboxil |
NDC Number |
31722063231 | 64380079701 | 00004080085 | 50242087701 | 50242086001 |
Product Dating |
| McKesson Acceptable Dating: we will ship >= 90 days | | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
Quantity |
10 Capsules | 10 Capsules | 10 Capsules | 1 Tablet | 1 Tablet |
Strength |
75 mg | 30 mg | 75 mg | 80 mg | 40 mg |
Type |
Unit Dose | Unit Dose | Gelcap | | Unit Dose |
UNSPSC Code |
51341805 | 51341805 | 51341805 | 51343300 | 51343300 |
Application |
Flu Prevention and Treatment Agent | Flu Prevention and Treatment Agent | Flu Prevention and Treatment Agent | Flu Prevention and Treatment Agent | Flu Prevention and Treatment Agent |
Container Type |
Blister Pack | Blister Pack | Blister Pack | Blister Pack | Blister Pack |
Country of Origin |
Unknown | Unknown | Unknown | Unknown | Unknown |
Features and Benefits |
|
|
|
|
- XOFLUZA is an influenza virus polymerase acidic (PA) endonuclease inhibitor indicated for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours
|